Skip to main content
Top
Published in: Journal of Clinical Immunology 4/2017

01-05-2017 | Original Article

Diagnostic Delay of Primary Immunodeficiencies at a Tertiary Care Hospital in Peru- Brief Report

Authors: Liz E. Veramendi-Espinoza, Jessica H. Zafra-Tanaka, Gabriela A. Pérez-Casquino, Wilmer O. Córdova-Calderón

Published in: Journal of Clinical Immunology | Issue 4/2017

Login to get access

Abstract

Objective

The aim of the study was to assess the diagnostic delay in pediatric patients with primary immunodeficiencies (PID) at a tertiary care hospital in Peru.

Methods

A descriptive study was carried out in which patients from a third-level referral center in Peru were included. Those without a specific diagnosis of PID were excluded. Data was collected by reviewing the medical records and interviewing patients’ family members.

Results

A total of 45 patients with a mean of 7.4 years (SD = 4.3) were studied. The most frequent diagnosis was predominant antibody defects (35.5%), and the diagnostic delay had a median of 12.17 months (IQR 5.1–30.3).

Conclusions

The most frequently diagnosed group of PID was predominant antibody deficiency. The overall median diagnostic delays for PID and predominant antibody deficiency were 12 and 14 months, respectively. Even though early detection of PIDs is crucial for effective treatment, current available laboratory tests required for PID diagnosis are both complex and expensive. Early detection and management of these pathologies cannot be achieved without training non-specialist health professionals in the diagnosis of PID, as well as integrating multidisciplinary and multi-center cooperation at both national and international levels.
Appendix
Available only for authorised users
Literature
1.
go back to reference Condino-Neto A, Sorensen RU, Gómez-Raccio AC, King A, Espinosa-Rosales FJ. Current state and future perspectives of the Latin American Society for Immunodeficiencies (LASID). Allergol Immunopathol. 2015;43(5):493–7.CrossRef Condino-Neto A, Sorensen RU, Gómez-Raccio AC, King A, Espinosa-Rosales FJ. Current state and future perspectives of the Latin American Society for Immunodeficiencies (LASID). Allergol Immunopathol. 2015;43(5):493–7.CrossRef
2.
go back to reference Raje N, Dinakar C. Overview of immunodeficiency disorders. Immunol Allergy Clin N Am. 2015;35(4):599–623.CrossRef Raje N, Dinakar C. Overview of immunodeficiency disorders. Immunol Allergy Clin N Am. 2015;35(4):599–623.CrossRef
3.
go back to reference Joshi AY, Iyer VN, Hagan JB, St JL. Sauver, Boyce TG. Incidence and temporal trends of primary immunodeficiency: a population-based cohort study. Mayo Clin Proc. 2009;84(1):16–22.CrossRefPubMedPubMedCentral Joshi AY, Iyer VN, Hagan JB, St JL. Sauver, Boyce TG. Incidence and temporal trends of primary immunodeficiency: a population-based cohort study. Mayo Clin Proc. 2009;84(1):16–22.CrossRefPubMedPubMedCentral
4.
go back to reference Bousfiha AA, Jeddane L, Ailal F, Benhsaien I, Mahlaoui N, Casanova J-L, et al. Primary immunodeficiency diseases worldwide: more common than generally thought. J Clin Immunol. 2013;33:1–7.CrossRefPubMed Bousfiha AA, Jeddane L, Ailal F, Benhsaien I, Mahlaoui N, Casanova J-L, et al. Primary immunodeficiency diseases worldwide: more common than generally thought. J Clin Immunol. 2013;33:1–7.CrossRefPubMed
5.
go back to reference Modell V, Knaus M, Modell F. An analysis and decision tool to measure cost benefit of newborn screening for severe combined immunodeficiency (SCID) and related T-cell lymphopenia. Immunol Res. 2014;60(1):145–52.CrossRefPubMed Modell V, Knaus M, Modell F. An analysis and decision tool to measure cost benefit of newborn screening for severe combined immunodeficiency (SCID) and related T-cell lymphopenia. Immunol Res. 2014;60(1):145–52.CrossRefPubMed
6.
go back to reference Reust CE. Evaluation of primary immunodeficiency disease in children. Am Fam Physician. 2013;87(11):773–8.PubMed Reust CE. Evaluation of primary immunodeficiency disease in children. Am Fam Physician. 2013;87(11):773–8.PubMed
7.
go back to reference Errante PR, Franco JL, Espinosa-Rosales FJ, Sorensen R, Condino-Neto A. Advances in primary immunodeficiency diseases in Latin America: epidemiology, research, and perspectives. Ann N Y Acad Sci. 2012;1250:62–72.CrossRefPubMed Errante PR, Franco JL, Espinosa-Rosales FJ, Sorensen R, Condino-Neto A. Advances in primary immunodeficiency diseases in Latin America: epidemiology, research, and perspectives. Ann N Y Acad Sci. 2012;1250:62–72.CrossRefPubMed
9.
go back to reference Ed V. European Society for Immunodeficiencies (ESID) members. Patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update. Clin Exp Immunol. 2011;167:108–19. Ed V. European Society for Immunodeficiencies (ESID) members. Patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update. Clin Exp Immunol. 2011;167:108–19.
10.
go back to reference Gathmann B, Goldacker S, Klima M, Belohradsky BH, Notheis G, Ehl S, et al. The German national registry for primary immunodeficiencies (PID). Clin Exp Immunol. 2013;173(2):372–80.CrossRefPubMedPubMedCentral Gathmann B, Goldacker S, Klima M, Belohradsky BH, Notheis G, Ehl S, et al. The German national registry for primary immunodeficiencies (PID). Clin Exp Immunol. 2013;173(2):372–80.CrossRefPubMedPubMedCentral
11.
go back to reference Edgar JD, Buckland M, Guzman D, Conlon NP, Knerr V, Bangs C, et al. The United Kingdom primary immune deficiency (UKPID) registry: report of the first 4 years’ activity 2008–2012. Clin Exp Immunol. 2014;175(1):68–78.CrossRefPubMed Edgar JD, Buckland M, Guzman D, Conlon NP, Knerr V, Bangs C, et al. The United Kingdom primary immune deficiency (UKPID) registry: report of the first 4 years’ activity 2008–2012. Clin Exp Immunol. 2014;175(1):68–78.CrossRefPubMed
12.
go back to reference Córdova-Calderón WO. Características clínicas y epidemiológicas de las inmunodeficiencias primarias en el Hospital Guillermo Almenara Irigoyen entre los años 2000 y 2010. [Tesis de postgrado]. Lima: Universidad Nacional Mayor de San Marcos (UNMSM); 2012. Córdova-Calderón WO. Características clínicas y epidemiológicas de las inmunodeficiencias primarias en el Hospital Guillermo Almenara Irigoyen entre los años 2000 y 2010. [Tesis de postgrado]. Lima: Universidad Nacional Mayor de San Marcos (UNMSM); 2012.
13.
go back to reference Picard C, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for primary immunodeficiency 2015. J Clin Immunol. 2015;35(8):696–726.CrossRefPubMedPubMedCentral Picard C, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for primary immunodeficiency 2015. J Clin Immunol. 2015;35(8):696–726.CrossRefPubMedPubMedCentral
14.
go back to reference Lugo-Reyes SO, Ramirez-Vazquez G, Hernández AC, Medina-Torres EA, Ramirez-Lopez AB, España-Cabrera C, et al. Clinical features, non-infectious manifestations and survival analysis of 161 children with primary immunodeficiency in Mexico: a single center experience over two decades. J Clin Immunol. 2014;36(1):56–65.CrossRef Lugo-Reyes SO, Ramirez-Vazquez G, Hernández AC, Medina-Torres EA, Ramirez-Lopez AB, España-Cabrera C, et al. Clinical features, non-infectious manifestations and survival analysis of 161 children with primary immunodeficiency in Mexico: a single center experience over two decades. J Clin Immunol. 2014;36(1):56–65.CrossRef
15.
go back to reference Ramírez-Roa JL, Vargas-Rumilla MI. Caracterización de inmunodeficiencias primarias en pacientes pediátricos que acudieron al Hospital Universitario Clínica San Rafael entre 2010 y 2014 [Tesis de postgrado]. Bogotá: Universidad Militar Nueva Granada; 2016. Ramírez-Roa JL, Vargas-Rumilla MI. Caracterización de inmunodeficiencias primarias en pacientes pediátricos que acudieron al Hospital Universitario Clínica San Rafael entre 2010 y 2014 [Tesis de postgrado]. Bogotá: Universidad Militar Nueva Granada; 2016.
16.
go back to reference Carneiro-Sampaio M, Morales-Vasconcelos D, Kokron CM, Jacob CMA, Toledo-Barros M, Dorna MB, et al. Primary immunodeficiency diseases in different age groups: a report on 1,008 cases from a single Brazilian reference center. J Clin Immunol. 2013;33(4):716–24.CrossRefPubMed Carneiro-Sampaio M, Morales-Vasconcelos D, Kokron CM, Jacob CMA, Toledo-Barros M, Dorna MB, et al. Primary immunodeficiency diseases in different age groups: a report on 1,008 cases from a single Brazilian reference center. J Clin Immunol. 2013;33(4):716–24.CrossRefPubMed
17.
go back to reference Poli C, Hoyos-Bachiloglu R, Borzutzky A. Primary immunodeficiencies in Chile evaluated through ICD-10 coded hospital admissions. Allergol Immunopathol (Madr). 2017;45(1):33–39 Poli C, Hoyos-Bachiloglu R, Borzutzky A. Primary immunodeficiencies in Chile evaluated through ICD-10 coded hospital admissions. Allergol Immunopathol (Madr). 2017;45(1):33–39
18.
go back to reference Al-Saud B, Al-Mousa H, Gazlan SA, Al-Ghonaium A, Arnaout R, Al-Seraihy A, et al. Primary immunodeficiency diseases in Saudi Arabia: a tertiary care hospital experience over a period of three years (2010–2013). J Clin Immunol. 2015;35(7):651–60.CrossRefPubMed Al-Saud B, Al-Mousa H, Gazlan SA, Al-Ghonaium A, Arnaout R, Al-Seraihy A, et al. Primary immunodeficiency diseases in Saudi Arabia: a tertiary care hospital experience over a period of three years (2010–2013). J Clin Immunol. 2015;35(7):651–60.CrossRefPubMed
19.
go back to reference de Oliveira DE, Aranda CS, Nobre FA, Fahl K, JTL M, Felix E, et al. Medical awareness concerning primary immunodeficiency diseases in the city of São Paulo, Brazil. Einstein (São Paulo, Brazil). 2013;11(4):479–85.CrossRef de Oliveira DE, Aranda CS, Nobre FA, Fahl K, JTL M, Felix E, et al. Medical awareness concerning primary immunodeficiency diseases in the city of São Paulo, Brazil. Einstein (São Paulo, Brazil). 2013;11(4):479–85.CrossRef
20.
go back to reference Al-Hammadi S, Al-Reyami E, Al-Remeithi S, Al-Zaabi K, Al-Zir R, Al-Sagban H, et al. Attentiveness of pediatricians to primary immunodeficiency disorders. BMC Res Notes. 2012;5:393. doi:10.1186/1756-0500-5-393. Al-Hammadi S, Al-Reyami E, Al-Remeithi S, Al-Zaabi K, Al-Zir R, Al-Sagban H, et al. Attentiveness of pediatricians to primary immunodeficiency disorders. BMC Res Notes. 2012;5:393. doi:10.​1186/​1756-0500-5-393.
21.
go back to reference Eley B, Esser M. Investigation and management of primary immunodeficiency in South African children. S Afr Med J 2014;104(11):793–96. Eley B, Esser M. Investigation and management of primary immunodeficiency in South African children. S Afr Med J 2014;104(11):793–96.
Metadata
Title
Diagnostic Delay of Primary Immunodeficiencies at a Tertiary Care Hospital in Peru- Brief Report
Authors
Liz E. Veramendi-Espinoza
Jessica H. Zafra-Tanaka
Gabriela A. Pérez-Casquino
Wilmer O. Córdova-Calderón
Publication date
01-05-2017
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 4/2017
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-017-0398-2

Other articles of this Issue 4/2017

Journal of Clinical Immunology 4/2017 Go to the issue